WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 22-Oct-2018 (data as of 18-Sep-2018)
Next overall update spring 2019
EPI mother and child logo         
Select a country

Development status: Developed economy GNI / capita (US$): 45'4401 Infant (under 12 months) mortality rate: 32
GDP / capita (US$): 52'5571 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 8'735  8'712  8'679  8'633  8'578  8'069  7'724  7'610 
Births 85  84  83  82  81  80  89  87 
Surviving infants 84  84  83  82  81  80  88  86 
Pop. less than 5 years 416  412  407  403  398  416  429  430 
Pop. less than 15 years 1'231  1'228  1'225  1'225  1'224  1'358  1'308  1'562 
Female 15-49 years 1'957  1'981  2'001  2'015  2'026  1'997  1'977  1'841 

Number of reported cases

(Click for retrospective incidence data for Austria)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  95  27  309  117 
Mumps
ChartChart
 
Pertussis
ChartChart
  1'411  1'270  579  370  117  234  186 
Polio*
ChartChart
 
Rubella
ChartChart
  39  11 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Austria)
Vaccine year result method % card seen                                                
BCG         
DTP1          94  95  75 
DTP3          90  87  98  81  90 
DTP4          60 
IPV1          94  95  98 
HepB_BD          65 
HepB3          90  87  98  33 
Hib3          90  87  98  72 
JapEnc         
MCV1          96  95  96  75  60 
MCV2          84  89  87  35 
MenA         
PCV1         
PCV2         
PCV3         
Pol3          90  87  98  71  90 
Rota1         
RotaC         
RCV1          96  95  96 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Austria)
BCG
  90 
DTP1
ChartChart
  94  95  97  99  98  99  96  96 
DTP3
ChartChart
  90  87  93  98  95  81  90  90 
HepB3
ChartChart
  90  87  93  98  95  33 
HepB_BD
 
Hib3
ChartChart
  90  87  93  98  95  72 
MCV1
ChartChart
  96  95  96  96  92  75  60 
MCV2
ChartChart
  84  89  88  87  82  35 
PCV3
 
Pol3
  90  87  93  98  95  71  90  90 
RCV1
ChartChart
  96  95  96  96  92  75  60 
RotaC
ChartChart
  61  61  61  61  61 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DTaPHibHepBIPV 2, 4, 11 months; Yes
HepB_Pediatric 12 years; Yes free catch up until Y14
HPV 9 years; +6 months; Yes Females and males
Influenza_Adult Yes elderly, adults with chronic illness, prenant women, health care workers, Haj or other travellers, other risk groups
Influenza_Pediatric Yes and children with chronic illness
MenACWY-135 conj 12 years; Yes
MMR 10 months; +1 months; Yes catch-up for everybody regardless of age
Pneumo_conj 2, 4, 11 months; Yes
Rotavirus 6, 10, 14 weeks; Yes
TdaPIPV 6 years; Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes         
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number NA             

System performance

Total Nº districts in country number     35    121  121 
Nº districts with DTP3 coverage >=80% number          
% of districts with DTP3 coverage >=80% From 0 to 100%              
Nº districts with measles (MCV1) coverage >=95% number              
% of districts with MCV1 coverage >=95% From 0 to 100%              

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes       

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes       

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.